Antipsychotics in Alzheimer's disease: A critical analysis (original) (raw)

Antipsychotics in Alzheimer's disease

Eduardo Marques da Silva

2011

View PDFchevron_right

ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia

Dilip Jeste, Dan Blazer

Neuropsychopharmacology, 2008

View PDFchevron_right

Role of antipsychotics for treating behavioral and psychological symptoms of dementia

Kai Zhen Yap

World Journal of Pharmacology, 2014

View PDFchevron_right

Antipsychotic Use in Dementia

Colleen Maxwell

The Canadian Journal of Psychiatry, 2016

View PDFchevron_right

Antipsychotics for behavioral and psychiatric symptoms of dementia: a reaudit in a specialist inpatient service

Camilla Haw

International Psychogeriatrics, 2014

View PDFchevron_right

Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence

Barbara Messinger-Rapport

Journal of the American Medical Directors Association, 2006

View PDFchevron_right

Antipsychotic Agents in Patients with Dementia

M. Crismon

Pharmacotherapy, 2000

View PDFchevron_right

Rethinking antipsychotic use in dementia: a literature review on efficacy, safety, and alternatives

Omar Basubrain

2024

View PDFchevron_right

Management of Neuropsychiatric Symptoms in People with Dementia

Anne Corbett

CNS Drugs, 2010

View PDFchevron_right

Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

jeffrey lieberman

New England Journal of Medicine, 2006

View PDFchevron_right

Neuropsychiatric symptoms in dementia: Importance and treatment considerations

Sally Sharp

International Review of Psychiatry, 2008

View PDFchevron_right

Use of atypical antipsychotic drugs in patients with dementia

Timothy Lacy

American Family Physician, 2003

View PDFchevron_right

Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review

Philip Lee

BMJ, 2004

View PDFchevron_right

Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia

Barbara Messinger-Rapport

JAMA, 2005

View PDFchevron_right

Antipsychotics in dementia: are they being appropriately prescribed?

Ridwan Ahmed

International …, 2010

View PDFchevron_right

Comparison of the Efficacy of New and Conventional Antipsychotic Drugs in the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)

Pietro Gareri

Archives of Gerontology and Geriatrics, 2004

View PDFchevron_right

A Systematic Review of the Efficacy and Safety of Atypical Antipsychotics in Patients with Psychological and Behavioral Symptoms of Dementia

Kim Peterson

Journal of the American Geriatrics Society, 2006

View PDFchevron_right

Use and safety of antipsychotics in behavioral disorders in elderly people with dementia

Pietro Gareri

Journal of Clinical Psychopharmacology, 2014

View PDFchevron_right

Pharmacological management of behavioural and psychological disturbance in dementia

John Wattis

Human Psychopharmacology: Clinical and Experimental, 2006

View PDFchevron_right

Prescribing patterns for psychotic and behavioural symptoms in dementia: a national survey

Elizabeth Brooks

Psychiatric Bulletin, 2002

View PDFchevron_right

Medications used in dementia: a review of evidence

Chathurie U Suraweera

Sri Lanka Journal of Psychiatry, 2015

View PDFchevron_right

Antipsychotics Continue to Have a Place in the Management of Difficult Behavior Problems in Patients With Dementia

George Grossberg

Journal of the American Medical Directors Association, 2013

View PDFchevron_right

Antidepressants for agitation and psychosis in patients with dementia

quynh bui

American family physician, 2012

View PDFchevron_right

Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials

Salvatore Gentile

Psychopharmacology, 2010

View PDFchevron_right

Treating Neuropsychiatric Symptoms of Alzheimer's disease: un update

Grazia D'Onofrio

International Journal of Geriatric Psychiatry, 2019

View PDFchevron_right

Guidelines on antipsychotics for dementia: are we losing our minds?

Graeme Yorston

Psychiatric Bulletin, 2009

View PDFchevron_right

Neuropsychiatric symptoms in dementia: Importance and treatment considerations Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College Introduction: Frequency and importance of dementia

Sally Sharp

View PDFchevron_right

Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease

Paulo Bertolucci

Journal of the Neurological Sciences, 2014

View PDFchevron_right

Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer's Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial

jeffrey lieberman

American Journal of Psychiatry, 2008

View PDFchevron_right

The treatment of behavioral disturbances and psychosis associated with dementia

Gerald Maguire

Psychiatria Polska, 2016

View PDFchevron_right

Association between antipsychotics and adverse outcomes in dementia

Sheliza Samnani

Progress in Neurology and Psychiatry, 2017

View PDFchevron_right

Pharmacological Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD) in Nursing Homes: Development of Practice Recommendations in a Swiss Canton

Olivier Bugnon

Journal of the American Medical Directors Association, 2008

View PDFchevron_right

Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study

CARLOS DANIEL SALCEDO MARTINEZ

BMJ open, 2013

View PDFchevron_right

Antipsychotics and Mortality in Dementia

Anne Corbett

American Journal of Psychiatry, 2012

View PDFchevron_right

Antipsychotic drug use and mortality in older adults with dementia

K L

2007

View PDFchevron_right